Appili Therapeutics Inc. (APLI.TO) TSX
0.02
+0(+33.33%)
Currency In CAD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.02
+0(+33.33%)
Currency In CAD
| Market Cap | 4.24M |
| Enterprise Value | 15.31M |
| P/E Ratio | -0.65 |
| PEG Ratio | -0.05 |
| Price/Sales Ratio | 9.33 |
| Price/Book Ratio | -0.12 |
| Enterprise/Revenue | 68.7 |
| Enterprise/EBITDA | -8.91 |
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -14.35 |
| Operating Margin | -15.17 |
| Return On Assets | -5.4 |
| Return On Equity | 0.2 |
| Revenue | 100,443 |
| Revenue/Share | 0 |
| Gross Profit | 100,443 |
| EBITDA | 360,566 |
| Net Income | -2.62M |
| Diluted EPS | -0.02 |
| Total Cash | 212,754 |
| Total Cash/Share | 0 |
| Total Debt | 12.46M |
| Total Debt/Equity | -0.76 |
| Current Ratio | 0.03 |
| Book Value Per Share | -0.13 |
| 52-Week Change | 0 |
| 52-Week High | 0.04 |
| 52-Week Low | 0.01 |
| Moving Average 50 Days | 0.02 |
| Moving Average 200 Days | 0.02 |
| Average Volume | 47,265 |
| Shares Outstanding | 128.37M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |